Cargando…
Clinical practice update of antifungal prophylaxis in immunocompromised children
Due to the rise in the number and types of immunosuppressed patients, invasive fungal infections (IFI) are an increasing and major cause of morbidity and mortality in immunocompromised adults and children. There is a broad group of pediatric patients at risk for IFI in whom primary and/or secondary...
Autores principales: | Ramos, José Tomás, Romero, Concepción Alba, Belda, Sylvia, Candel, Francisco Javier, Gallego, Begoña Carazo, Fernández-Polo, Aurora, Antolín, Laura Ferreras, Colino, Carmen Garrido, Navarro, María Luisa, Neth, Olaf, Olbrich, Peter, Rincón-López, Elena, Contreras, Jesús Ruiz, Soler-Palacín, Pere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790888/ https://www.ncbi.nlm.nih.gov/pubmed/31507152 |
Ejemplares similares
-
Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016) -
Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study
por: Mendoza-Palomar, Natalia, et al.
Publicado: (2021) -
Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021) -
The Current State of Antifungal Stewardship in Immunocompromised Populations
por: Alegria, William, et al.
Publicado: (2021) -
Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)